Can a simple inhalation treatment help COVID-19 patients breathe easier?

NCT ID NCT04469491

Ongoing Disease control Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if inhaling a protein called interferon beta 1b can help hospitalized COVID-19 patients who need oxygen. The goal is to see if the treatment reduces the amount of oxygen they need over 15 days. The study includes 74 adults with confirmed COVID-19 who are on oxygen therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID-19 INTERFERON NEBULIZATION

Contacts and locations

Locations

CH Compiègne-Noyon

Compiègne, 60200, France
CH d'Abbeville

Abbeville, 80142, France
CH de Saint-Quentin

Saint-Quentin, 02100, France
CH de Tourcoing

Tourcoing, 59208, France
CH de l'Arrondissement de Montreuil-sur-mer

Rang-du-Fliers, 62180, France
CH de valenciennes

Valenciennes, 59322, France
CHU Amiens

Amiens, 80480, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.